Cargando…
Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model
Colorectal cancer (CRC) is a common malignancy occurring in the digestive system. Despite progress in surgery and therapy options, CRC is still a considerable cause of cancer mortality worldwide. In this study, a colon cancer patient-derived xenograft model was established to evaluate the antitumor...
Autores principales: | Chen, Yang, Ni, Juan, Gao, Yun, Zhang, Jinghui, Liu, Xuesong, Chen, Yong, Chen, Zhongjian, Wu, Yongjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445290/ https://www.ncbi.nlm.nih.gov/pubmed/32839531 http://dx.doi.org/10.1038/s41598-020-71116-5 |
Ejemplares similares
-
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer
por: Chen, Yang, et al.
Publicado: (2020) -
Evaluation of the antitumor effects of PP242 in a colon cancer xenograft mouse model using comprehensive metabolomics and lipidomics
por: Rashid, Md Mamunur, et al.
Publicado: (2020) -
Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
por: Gao, Yun, et al.
Publicado: (2022) -
Combination of GC-MS based metabolomics analysis with mouse xenograft models reveals a panel of dysregulated circulating metabolites and potential therapeutic targets for colorectal cancer
por: Ni, Juan, et al.
Publicado: (2021) -
Shikonin induces ROS-based mitochondria-mediated apoptosis in colon cancer
por: Liang, Wenquan, et al.
Publicado: (2017)